Abeona Therapeutics (ABEO) Interest Expenses (2011 - 2026)

Abeona Therapeutics' Interest Expenses history runs 15 years deep, the most recent figure standing at $830000.0 for Q1 2026.

• In Q1 2026, Interest Expenses fell 16.83% year-over-year to $830000.0; the TTM figure through Mar 2026 stood at $3.6 million (down 16.03% YoY), while the FY2025 annual figure was $3.7 million, down 11.12% from the prior year.
• Interest Expenses was $830000.0 for Q1 2026 at Abeona Therapeutics, down from $884000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $1.1 million in Q3 2024 to a low of $101000.0 in Q1 2023.
• Historically, Interest Expenses has averaged $584235.3 across 5 years, with a median of $830000.0 in 2026.
• The sharpest annual moves came in 2022 and 2024: Interest Expenses sank 86.67% in 2022, then soared 949.52% in 2024.
• A 5-year view of Interest Expenses shows it stood at $178000.0 in 2022, then plunged by 38.76% to $109000.0 in 2023, then jumped by 892.66% to $1.1 million in 2024, then fell by 18.3% to $884000.0 in 2025, then retreated by 6.11% to $830000.0 in 2026.
• The last three Interest Expenses figures came in at $830000.0 (Q1 2026), $884000.0 (Q4 2025), and $901000.0 (Q3 2025), per Business Quant data.